The suppression of the NLRP-3 gene in rats with type 2 diabetes resulted in the mitigation of DCM by improving cardiac function and reducing cardiac inflammation, cardiomyocyte pyroptosis, and left ventricular fibrosis [94]. This evidence concerns the gene NLRP3 and familial dilated cardiomyopathy.